$109 Million is the total value of Blackcrane Capital, LLC's 10 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXNX | Buy | AXONICS MODULATION TECHNOLOG | $19,066,000 | +52.6% | 750,339 | +66.4% | 17.43% | +74.8% |
| WIX | Buy | WIX.COM LTD | $17,107,000 | +32.1% | 169,674 | +60.3% | 15.64% | +51.3% |
| V | Buy | VISA INC-CLASS A SHARES | $5,321,000 | +7.3% | 33,024 | +25.1% | 4.86% | +22.9% |
| PROF | New | PROFOUND MEDICAL CORP | $2,167,000 | – | 222,547 | +100.0% | 1.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 14 | Q4 2021 | 20.2% |
| NICE LTD - SPON ADR | 13 | Q1 2022 | 18.1% |
| TAKEDA PHARMACEUTIC-SP ADR | 13 | Q1 2022 | 19.3% |
| WIX.COM LTD | 10 | Q1 2022 | 24.7% |
| PROFOUND MEDICAL CORP | 9 | Q1 2022 | 15.6% |
| AXONICS MODULATION TECHNOLOG | 9 | Q4 2021 | 17.4% |
| AVITA THERAPEUTICS INC | 8 | Q1 2022 | 31.8% |
| BIOHAVEN PHARMACEUTICAL HOLD | 6 | Q4 2020 | 14.9% |
| VISA INC-CLASS A SHARES | 5 | Q1 2020 | 14.9% |
| HDFC BANK LTD-ADR | 5 | Q1 2022 | 21.7% |
View Blackcrane Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-10 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-12 |
View Blackcrane Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.